RCGP and Cancer Research UK Workshop

Slides:



Advertisements
Similar presentations
Midland Region Primary Healthcare Forum 30 May 2014.
Advertisements

Shaping a blueprint for cancer Plymouth Cancer Summit Sean Duffy February 2015.
Achieving improved cancer outcomes- a pathway approach, engaging primary care and partners Kathy Elliott Programme Director – NHS Improving Quality (Delivery.
Beyond Primary Treatment Professor Jane Maher Joint Chief Medical Officer Macmillan Cancer Support.
Lymphoedema Management: the Northern Ireland Model Jane Rankin Regional Lead Lymphoedema Network Northern Ireland (LNNI) February 2010.
National Perspective Cancer Early Detection & Prevention Performance Review Event October 2008 National Cancer Action Team Kathy Elliott National Lead.
Our Plans for 2015/16 We want to make sure that people in our area are able to live long and healthy lives, both now and in the future, and our plans set.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
Linda Devereux Associate Director Merseyside and Cheshire Cancer Network - why we are here and what’s next!
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
BETTER CANCER CARE A Discussion Elizabeth Porterfield Head, NHS National Planning Team SGHD.
Equal Treatment: Closing the gap Final results. Why we investigated ‘Far too many people…are dying in their 40s, 50s or even younger – far more than in.
Supporting people with active and advanced disease Need better data collection Discussion at MDT – new diagnosis support Identify best practice Early palliative.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
Slide 1 UCLH Cancer Collaborative (part of the National Cancer Vanguard with RM Partners, and Greater Manchester Cancer)
Where can I find data on cancer? Victoria H Coupland London Knowledge and Intelligence Team 20 February 2014.
What does the cancer intelligence landscape look like now? Dr Mick Peake Clinical Lead, National Cancer Intelligence Network.
2016 Implementing the Recovery Package. 1. Overview of Living with and Beyond Cancer 2.Promote wider understanding of Recovery Package 3.Explore stratification.
[NAME CCG] [DATE] [FACILITATOR] Early Diagnosis of Cancer Quality Improvement using Cancer Significant Event Analysis [CCG MAP]
Transforming Population Health in Greater Manchester – New Economy Breakfast Seminar – 13 July 2016.
Taunton Vale Sports Club 30th November 2016
Cancer Update for Primary Care GPVTS Teaching
Early Diagnosis and Prognostic Indicator
RCGP and Cancer Research UK Workshop
Transforming the cancer journey
Sustainability and Transformation Partnership
Macmillan Next Steps Cancer Rehabilitation
Dementia Risk Reduction Melanie Earlam PHE 27th September 2016
Annual General Meeting
Dr Daniel Anderson Consultant psychiatrist
The Ambition: Achieving 25% 5 Year Survival By 2025
Jane E Scullion Respiratory Nurse Consultant
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
Achieving World-Class Cancer Outcomes: Taking the strategy forward May 2016 “People affected by cancer – those living with it and those supporting relatives.
Dr James Carlton, Medical Adviser
Stafford and Cannock Trainers’ Workshop
Kate Yorke, Project Manager – MECC
HEALTH PROFESSIONAL ENGAGEMENT PROGRAMME:
Northern Cancer Alliance
Hereford and Worcester Sub Regional Trainers’ Workshop
Fiona Caplan-Dean Pharmacy Services Development Manager UK
Challenges Vision ‘How’ Objectives Outcome Aspirations
Achieving World-Class Cancer Outcomes A Strategy for England
BOWEL CANCER SCREENING 11/7/18
Primary care engagement Programme
Local Tobacco Control Profiles The webinar will start at 1pm
Kate Yorke, Project Manager – MECC
15/16 Achievements and ambition for 16/17
Achieving World-Class Cancer Outcomes A Strategy for England
West MidlandsTrainers’ Workshop
National Cancer Diagnosis Audit
Achieving World-Class Cancer Outcomes A Strategy for England
Effective and humane care for all with mental, neurological,
Tit Albreht | Brussels | 7 November 2017
Achieving World-Class Cancer Outcomes A Strategy for England
GP Trainers' Workshop 13th September 2018
28th November 2016 – First Meeting
Achieving World-Class Cancer Outcomes A Strategy for England
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Nuzhat Ali, National Lead MSK Health
Achieving World-Class Cancer Outcomes A Strategy for England
1. Reduce harms from the main preventable causes of poor health
High Blood Pressure in General Practice: Variation and Opportunities South Cheshire CCG (v11) 5th March 2019.
How will the NHS Long Term Plan work in our community?
Value Based Healthcare King’s Health Partners
Dr Timothy Armstrong Coordinator
NHS LONG TERM PLAN.
Cancer prevention policy in the EU:
NHS Long Term Plan: Rapid Diagnostic Centres (RDC) The SWAG Approach
Tools to support development of interventions Soili Larkin & Mohammed Vaqar Public Health England West Midlands.
Presentation transcript:

RCGP and Cancer Research UK Workshop Hallmark Hotel, Leyland Way, Leyland, Preston, PR25 4JX 11th July 2018 Dr Richard Roope RCGP and Cancer Research UK Cancer Clinical Champion Senior Clinical Advisor Cancer Research UK

RCGP and Cancer Research UK Workshop Housekeeping Fire Exits Toilets Mobile phones Questions Certificates Thanks to the team who have set up the day: RCGP and Cancer Research UK Team Hallmark Hotel Staff

RCGP and Cancer Research UK Workshop The Day: The expanding role of Primary Care and Cancer Control Tea and Coffee Implementation of NG12 (recognition and referral of suspected cancer) and vague symptoms Lunch and networking Bowel Cancer Screening North West Project Insights from the National Cancer Diagnosis Audit and Multi-Diagnostic Centre Evaluation Optimal Lung Cancer Pathway Key take home, evaluation and close

RCGP and Cancer Research UK Workshop Primary Care and Cancer Control

RCGP and Cancer Research UK Workshop Primary Care and Cancer Control Cancer: why all the interest? Why is early diagnosis important? Past – where were we? Present – where are we? Future – where next? Survivorship End of life care

RCGP and Cancer Research UK Workshop Cancer: why all the interest?

RCGP and Cancer Research UK Workshop Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver

RCGP and Cancer Research UK Workshop Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver Which do you think is the correct column? (high to low)

RCGP and Cancer Research UK Workshop Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver

RCGP and Cancer Research UK Workshop Cancer: why all the interest? https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/307703/LW4L.pdf (last accessed 17.6.17)

RCGP and Cancer Research UK Workshop Cancer: why all the interest? 37% https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/307703/LW4L.pdf Last accessed 9.6.18

RCGP and Cancer Research UK Workshop Cancer: why all the interest? https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/307703/LW4L.pdf (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop Cancer – why all the interest RCGP and Cancer Research UK Workshop Cancer – why all the interest? The Future:

RCGP and Cancer Research UK Workshop The perfect storm:

RCGP and Cancer Research UK Workshop The perfect storm:

RCGP and Cancer Research UK Workshop The Scale of the Challenge: The perfect storm…

RCGP and Cancer Research UK Workshop The Scale of the Challenge: The perfect storm… Aging population

RCGP and Cancer Research UK Workshop Aging Population Life expectancy 1960-2015 UK Higher Income countries https://data.worldbank.org/indicator/SP.DYN.LE00.IN?end=2015&locations=GB-XD&start=1960&view=chart&year_high_desc=true (Accessed 9.6.18)

RCGP and Cancer Research UK Workshop Aging Population - Centenarians 2013 2063 X Male 2,242 43,689 19.5 Female 12,328 66,359 5.4 TOTAL 14,750 110,048 7.5 http://www.ons.gov.uk/ons/rel/lifetables/historic-and-projected-data-from-the-period-and-cohort-life-tables/2012-based/info-surviving-to-age-100.html last accessed 9.6.18 https://visual.ons.gov.uk/what-are-your-chances-of-living-to-100/ last accessed 9.6.18

RCGP and Cancer Research UK Workshop Aging Population - Centenarians https://visual.ons.gov.uk/what-are-your-chances-of-living-to-100/ last accessed 9.6.18

RCGP and Cancer Research UK Workshop Aging and Cancer

RCGP and Cancer Research UK Workshop Aging and Cancer Male Female Mortality from all cancers http://www-dep.iarc.fr/WHOdb/Graph2p.asp?cancer=150&sex=1&country=4308&sYear=1950&eYear=2013&age=0&agegr=10&agen=9&orientation=1&window=1&grid=1&line=2&moving=1&scale=0&submit=%A0%A0%A0Execute%A0%A0%A0 last accessed 9.6.18

RCGP and Cancer Research UK Workshop Aging and Cancer Male Female Mortality from all cancers http://www-dep.iarc.fr/WHOdb/Graph2p.asp?cancer=150&sex=1&country=4308&sYear=1950&eYear=2013&age=0&agegr=10&agen=9&orientation=1&window=1&grid=1&line=2&moving=1&scale=0&submit=%A0%A0%A0Execute%A0%A0%A0 last accessed 9.6.18

RCGP and Cancer Research UK Workshop The Scale of the Challenge: The perfect storm… Aging population Lifestyles less healthy: Smoking Weight Diet Alcohol Exercise Sun exposure

RCGP and Cancer Research UK Workshop The Scale of the Challenge: The perfect storm… Aging population Lifestyles less healthy: Smoking Weight Diet Alcohol Exercise Sun exposure Increasing survival

RCGP and Cancer Research UK Workshop The perfect storm: Numbers of cancers 2013 2030 % increase UK 352,000 424,789 20.7% Global 14.1 million 23.6 million 67.4% http://globocan.iarc.fr/old/burden.asp?selection_pop=206826&Text-p=United+Kingdom&selection_cancer=290&Text-c=All+cancers+excl.+non-melanoma+skin+cancer&pYear=18&type=0&window=1&submit=%C2%A0Execute last accessed 9.6.18 http://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer/incidence#heading-Five Last accessed 9.6.18

RCGP and Cancer Research UK Workshop The Scale of the Challenge: By the end of 2016, there were 1,000 people in the UK being diagnosed with cancer every day Mistry, M., et al., Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer, 2011. 105: p. 17951803.

RCGP and Cancer Research UK Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime

RCGP and Cancer Research UK Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50%

RCGP and Cancer Research UK Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50% www.cancerresearchuk.org/health-professional/cancer-statistics/survival/all-cancers-combined#heading-One – last accessed 17.2.18

RCGP and Cancer Research UK Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50%, but… Cancer survival in the UK still lags behind comparable health economies

RCGP and Cancer Research UK Workshop Hasn’t cancer had its turn?

RCGP and Cancer Research UK Workshop Hasn’t cancer had its turn? Cancer receives what proportion of NHS spend? 2.0% 5.0% 8.0% 11.0% 14.0% Discuss with your neighbour….

RCGP and Cancer Research UK Workshop Hasn’t cancer had its turn? Cancer receives what proportion of NHS spend? 2.0% 5.0% 8.0% 11.0% 14.0% Discuss with your neighbour….

RCGP and Cancer Research UK Workshop 168€ 128€ http://ihe.se/wp-content/uploads/2016/08/IHE-Report_2016_4.pdf last accessed 9.6.18

RCGP and Cancer Research UK Workshop Why is early diagnosis important?

RCGP and Cancer Research UK Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/survival#heading-Three (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop Why is early diagnosis important?

RCGP and Cancer Research UK Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/survival#heading-Two (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop Why is early diagnosis important?

RCGP and Cancer Research UK Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer/survival#heading-Three (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop Why is early diagnosis important?

RCGP and Cancer Research UK Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/survival#heading-Three (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop Why is early diagnosis important?

Proportion of Cases Diagnosed at Each Stage RCGP and Cancer Research UK Workshop Why is early diagnosis important? Proportion of Cases Diagnosed at Each Stage www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/all-cancers-combined#heading-Two (last accessed 17.2.18)

Proportion of Cases Diagnosed at Each Stage RCGP and Cancer Research UK Workshop Why is early diagnosis important? Proportion of Cases Diagnosed at Each Stage Stage Shift www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/all-cancers-combined#heading-Two (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop Minimum increased 5 year survival with 10% increase in stages 1 & 2 Colorectal 4.00% Ovary Breast 3.80% Endometrium 3.70% Prostate 2.40% Melanoma 2.30% Lung 2.00% Kidney Bladder 1.30% NHL 0.20% https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/388160/fourth_annual_report.pdf (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop How are we doing?

RCGP and Cancer Research UK Workshop How did we do? https://fingertips.phe.org.uk/profile/cancerservices

RCGP and Cancer Research UK Workshop How did we do? https://fingertips.phe.org.uk/profile/cancerservices

RCGP and Cancer Research UK Workshop How did we do? https://fingertips.phe.org.uk/profile/cancerservices (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop How did we do? https://fingertips.phe.org.uk/profile/cancerservices (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop   Emergency Diagnosis % Dec-12 21.0% Mar-13 Jun-13 20.8% Sep-13 20.5% Dec-13 20.4% Mar-14 20.3% Jun-14 20.2% Sep-14 Dec-14 Mar-15 20.1% Jun-15 Sep-15 20.0% Dec-15 19.9% Mar-16 Jun-16 19.7% Sep-16 19.8% Dec-16 Mar-17 19.5% Jun-17 19.4% Sep-17 19.2% How have we done? http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/cancer_outcome_metrics (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop   Emergency Diagnosis % Dec-12 21.0% Mar-13 Jun-13 20.8% Sep-13 20.5% Dec-13 20.4% Mar-14 20.3% Jun-14 20.2% Sep-14 Dec-14 Mar-15 20.1% Jun-15 Sep-15 20.0% Dec-15 19.9% Mar-16 Jun-16 19.7% Sep-16 19.8% Dec-16 Mar-17 19.5% Jun-17 19.4% Sep-17 19.2% How have we done? http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/cancer_outcome_metrics (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop How have we done?   Early Stage Diagnosis Sep-13 46% Dec-13 47% Mar-14 48% Jun-14 49% Sep-14 50% Dec-14 Mar-15 51% Jun-15 Sep-15 52% Dec-15 Mar-16 Jun-16 53% Sep-16 Dec-16 http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/cancer_outcome_metrics (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop How have we done? https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/table10to161yearcancersurvivalbyclinicalcommissioninggroupinenglandwith95confidenceintervals (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop Variation: Lancashire and South Cumbria NHS Region http://lci.cancertoolkit.co.uk/Survival (last accessed 5.3.17)

RCGP and Cancer Research UK Workshop Variation: Lincolnshire CCGs http://www.ncin.org.uk/cancer_type_and_topic_specific_work/topic_specific_work/cancer_outcome_metrics (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop ONS Press release 29.11.17: “The one-year all-cancer survival index for England increased steadily from 61.2% for patients diagnosed in 2000 to 72.3% in 2015.” https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/indexofcancersurvivalforclinicalcommissioninggroupsinengland/adultsdiagnosed2000to2015andfollowedupto2016 (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop ONS Press release 29.11.17: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/indexofcancersurvivalforclinicalcommissioninggroupsinengland/adultsdiagnosed2000to2015andfollowedupto2016 (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop ONS Press release 29.11.17: “The inequality gap in the cancer survival index between the highest and lowest CCG in England has shrunk since 2000.” “As for CCGs, the inequality gap between the highest and lowest STP in England has reduced since 2000, having halved for STPs over this period.” https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/indexofcancersurvivalforclinicalcommissioninggroupsinengland/adultsdiagnosed2000to2015andfollowedupto2016 (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop However compared to Europe?

RCGP and Cancer Research UK Workshop However compared to Europe? http://scienceblog.cancerresearchuk.org/2015/08/05/cancer-survival-in-england-is-improving-but-still-lagging-behind-similar-countries/

RCGP and Cancer Research UK Workshop However compared to Europe? http://scienceblog.cancerresearchuk.org/2015/08/05/cancer-survival-in-england-is-improving-but-still-lagging-behind-similar-countries/

RCGP and Cancer Research UK Workshop Why do we lag behind other Health Systems?

RCGP and Cancer Research UK Workshop Why do we lag behind other Health Systems? International Cancer Benchmarking Partnership As gatekeepers – the gate needs to be wider Outcomes closely linked to “readiness to act” Patients fear wasting GP time Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? British Journal of Cancer (2013) 108, 292–300. doi:10.1038/bjc.2012.542 (last accessed 17.6.17)

RCGP and Cancer Research UK Workshop Gate openers…

RCGP and Cancer Research UK Workshop

RCGP and Cancer Research UK Workshop

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life Invest now to save later www.cancerresearchuk.org/sites/default/files/achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf (last accessed 21.1.17)

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives - <75 preventable cancers Under 75 mortality rate for cancer considered preventable https://fingertips.phe.org.uk/profile/public-health-outcomes-framework/data#page/8/gid/1000044/pat/6/par/E92000001/ati/101/are/E12000004/iid/40501/age/163/sex/4 (last accessed 9.6.18)

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Ambition:

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Ambition: Fall in age-standardised incidence Adult smoking rates to fall to 13% (currently 17.5%)

Cancer Control in Primary Care Smoking prevalence in UK http://www.smokinginengland.info/latest-statistics/ (last accessed 17.2.18)

Cancer Control in Primary Care Smoking prevalence in UK 21% target by 2020 13% target by 2020 Dec-20 http://www.smokinginengland.info/latest-statistics/ (last accessed 9.6.18)

Cancer Control in Primary Care Smoking prevalence in UK 21% target by 2020 13% target by 2020 Dec-20 http://www.smokinginengland.info/latest-statistics/ (last accessed 9.6.18)

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Smoking cessation:

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Smoking cessation: £1 investment leads to a return of (including NHS savings and value of health gains) 2 years £ 0.63 5 years £ 1.46 10 years £ 2.82 Lifetime £ 9.35

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Weight management:

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention http://www.cancerresearchuk.org/health-professional/cancer-statistics/risk/overweight-and-obesity#heading-Two (last accessed 9.6.18)

Cancer Control in Primary Care Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Spearhead a radical upgrade in prevention Weight management: PHE: “Let’s talk about weight”

Cancer Control in Primary Care Weight management: PHE: “Let’s talk about weight” https://www.gov.uk/government/publications/adult-weight-management-a-guide-to-brief-interventions (last accessed 17.2.18)

Cancer Control in Primary Care Prevention – Brown et al (2018)recent update to Parkin et al (2010): Parkin, D. M. et al. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br. J. Cancer 105, Si–S81 (2011). Brown, K..F. et al. The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015 British Journal of Cancer https://doi.org/10.1038/s41416-018-0029-6

Cancer Control in Primary Care Prevention – Interactive CRUK risk calculator http://www.cancerresearchuk.org/about-cancer/causes-of-cancer/cancer-risk-health-quiz

Cancer Control in Primary Care Prevention – Interactive CRUK risk calculator http://www.cancerresearchuk.org/about-cancer/causes-of-cancer/cancer-risk-health-quiz

Cancer Control in Primary Care Prevention – WCRF report https://www.wcrf.org/dietandcancer (last accessed 12.6.18)

Cancer Control in Primary Care Prevention – WCRF report – interactive cancer risk matrix https://www.wcrf.org/dietandcancer/interactive-cancer-risk-matrix#download_block (last accessed 12.6.18)

Cancer Control in Primary Care Prevention – WCRF report https://www.wcrf.org/dietandcancer/interactive-cancer-risk-matrix#download_block (last accessed 12.6.18)

Cancer Control in Primary Care Prevention – WCRF report – 10 recommendations https://www.wcrf.org/dietandcancer/cancer-prevention-recommendations (last accessed 12.6.18)

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift Ambition: Increase 5ys and 10ys – with 57% surviving 10+ years Increase 1ys to 75% with reduction of variation

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift “If the taskforce recommendations are implemented 30,000 cancer deaths a year could be saved by 2020, of these 11,000 will be through early diagnosis”

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives: Spearhead a radical upgrade in prevention Drive a national ambition to achieve earlier diagnosis, and with it stage shift “If the taskforce recommendations are implemented 30,000 cancer deaths a year could be saved by 2020, of these 11,000 will be through early diagnosis”

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Early Diagnosis Implement NICE Guidance (NG12) Invest in diagnostic capacity Direct access to diagnostic capacity Enhance screening uptake 28 days to diagnosis (to replace 2WW) Education – Undergraduate, postgraduate, CPD

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life Patient experience to be given as high a priority as clinical effectiveness and safety Transform approach to support those living with and beyond cancer Continuous improvement in patient experience, with reduction in variation Continuous improvement in long-term quality of life

RCGP and Cancer Research UK Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life Invest now to save later

RCGP and Cancer Research UK Workshop

RCGP and Cancer Research UK Workshop Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement

RCGP and Cancer Research UK Workshop Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement Primary Care could (should?) have a part to play throughout the cancer pathway, and is well placed to do so…

RCGP and Cancer Research UK Workshop Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement Primary Care could (should?) have a part to play throughout the cancer pathway, and is well placed to do so…if adequately resourced…

RCGP and Cancer Research UK Workshop The Lancet Oncology: “The expanding role of Primary Care in Cancer Control” “For a long time, the role of primary care in cancer was largely seen a peripheral, but as prevention, diagnosis, survivorship, and end-of-life care assume greater importance in cancer policy, the defining characteristics of primary care become more important” The Lancet Oncology, Vol. 16, No. 12

RCGP and Cancer Research UK Workshop The Lancet Oncology: “The expanding role of Primary Care in Cancer Control” “The strengths of primary care—its continuous, coordinated, and comprehensive care for individuals and families—are particularly evident in prevention and diagnosis, in shared follow-up and survivorship care, and in end-of-life care. ” The Lancet Oncology, Vol. 16, No. 12

RCGP and Cancer Research UK Workshop The Lancet Oncology: “The expanding role of Primary Care in Cancer Control” “recommendations should be implemented by all stakeholders involved in cancer care…work should start now to ensure that patients get the optimum care to prevent, receive a diagnosis of, and survive cancer, and the best possible care should they die from the disease” The Lancet Oncology, Vol. 16, No. 12

RCGP and Cancer Research UK Workshop Value in investing in early diagnosis:

RCGP and Cancer Research UK Workshop Value in investing in early diagnosis: Why? To address our lowly cancer outcomes rank How? To lower threshold/readiness to refer with consistency When? Now

RCGP and Cancer Research UK Workshop Value in investing in early diagnosis: Results?

RCGP and Cancer Research UK Workshop Value in investing in early diagnosis: Results? Better medicine – earlier diagnosis (not just of cancer) Fewer consultations Better outcomes Less complaints/litigation Less £££

RCGP and Cancer Research UK Workshop Living with and beyond cancer:

RCGP and Cancer Research UK Workshop Living with and beyond cancer: Rising cancer incidence Falling cancer mortality

RCGP and Cancer Research UK Workshop Living with and beyond cancer: Projections of cancer prevalence in the United Kingdom, 2010–2040 J Maddams, M Utley and H Møller

RCGP and Cancer Research UK Workshop Survivorship:

RCGP and Cancer Research UK Workshop Survivorship: Problems faced by cancer survivors: Physical Psychological Social Financial

RCGP and Cancer Research UK Workshop Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment Immediate (eg radiation proctitis) Late (eg ↑ x5 incidence of congestive heart failure after radiotherapy or chemotherapy for NHL) 10+ years after treatment

RCGP and Cancer Research UK Workshop Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment

RCGP and Cancer Research UK Workshop Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment

RCGP and Cancer Research UK Workshop Survivorship: Problems faced by cancer survivors: Physical Consequences of treatment

RCGP and Cancer Research UK Workshop Survivorship: Problems faced by cancer survivors: Physical Co-morbidities Living with other long-term conditions as well as cancer reduces people’s chance of survival and increases their level of support needs. It also increases the cost of treatment1. 1. Macmillan Cancer Support. Routes from Diagnosis research programme. Unpublished data.

RCGP and Cancer Research UK Workshop Survivorship: Problems faced by cancer survivors: Physical Co-morbidities Proportion of people with cancer living with one or more other long-term health conditions, by age group

RCGP and Cancer Research UK Workshop Risk factors common to other long term conditions:

RCGP and Cancer Research UK Workshop Risk factors common to other long term conditions: Aging population Lifestyles less healthy: Smoking Diet Alcohol Exercise Sun exposure

RCGP and Cancer Research UK Workshop Risk factors common to other long term conditions: Aging population Lifestyles less healthy: Smoking Diet Alcohol Exercise Sun exposure Hypertension Heart disease Stroke Diabetes Dementia Mental Health Problems…

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Physical Recurrence

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Physical Recurrence – can be reduced

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Physical Recurrence – can be reduced Smoking Diet Alcohol Exercise Sun exposure

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Second (and third…) cancers.

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Second (and third…) cancers.

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Second (and third…) cancers. Of the 1.6 million people expected to be diagnosed with cancer this year in the U.S., about one in six will have already survived a different cancer before being developing this new one, according to statistics from the National Cancer Institute (NCI). Paraphrased from: http://www.cancertodaymag.org/Spring2013/Pages/Second-Cancers2.aspx

RCGP and Cancer Research UK Workshop Second (and third…) cancers. Many preventable (c 40%): Smoking Diet Alcohol Exercise Sun exposure

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Physical Psychological 21% of patients living beyond cancer had MH problems Consequences of treatment – 10% develop major depression1. Pre-existing 1. Walker, J., et al., Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. The Lancet Psychiatry, 2014. 1(5): p. 343-350.

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Physical Psychological Social Consequences of treatment – impact on family and communities. Pre-existing – deprivation gradient

RCGP and Cancer Research UK Workshop http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/deprivation-gradient#heading-Zero (last accessed 17.2.18)

RCGP and Cancer Research UK Workshop Problems faced by cancer survivors: Physical Psychological Social Financial Consequences of treatment Loss of job/overtime for patient and carer

RCGP and Cancer Research UK Workshop Survivorship - Exercise

RCGP and Cancer Research UK Workshop Survivorship - Exercise Role of cancer rehab: Helps short term: Fatigue, stress, depression, quality of life Helps long term: Breast cancer patients 150 mins of exercise per week 40% cancer mortality Bowel cancer 6 hours of exercise per week 50% cancer mortality Prostate cancer 3 hours of exercise per week 30% cancer mortality Holmes, MD et al. Physical activity andsurvival after breast cancer diagnosis. JAMA.25 May 2005. 293(20):2479–86. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006. 24:3527–3534. Kenfield SA, Stampfer MJ, Giovannucci, E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-upstudy. J Clin Oncol.2011. 29:726–732.

RCGP and Cancer Research UK Workshop Survivorship - Exercise https://www.walkingforhealth.org.uk/ (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop https://www.walkingforhealth.org.uk/walk/search/Lincoln%2CLincolnshire (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop As survivorship increases: Co-morbidity Second cancers: previous history cancer risk other cancer E.g: Bowel: risk of prostate cancer by 32% Complication of treatment: E.g: pelvic radiation

RCGP and Cancer Research UK Workshop End of Life Care

RCGP and Cancer Research UK Workshop End of Life Care Palliative Care increasingly seen as “non-curative treatment and support”

RCGP and Cancer Research UK Workshop End of Life Care

RCGP and Cancer Research UK Workshop End of Life Care https://www.eiuperspectives.economist.com/sites/default/files/images/2015%20EIU%20Quality%20of%20Death%20Index%20Oct%2029%20FINAL.pdf (last accessed 9.6.18 )

RCGP and Cancer Research UK Workshop End of Life Care A third of those diagnosed with cancer will die form their disease Most express preference to die at home

RCGP and Cancer Research UK Workshop Dying at home 2010-12 http://apps.mariecurie.org.uk/marie-curie-atlas/html5/atlas.html (last accessed 9.6.18)

RCGP and Cancer Research UK Workshop Dying at home 2010-12 http://apps.mariecurie.org.uk/marie-curie-atlas/html5/atlas.html (last accessed 10.11.17)

RCGP and Cancer Research UK Workshop What’s new?

RCGP and Cancer Research UK Workshop What’s new? Output from the National Cancer Transformation Board Delivery infrastructure: National Cancer Vanguard and Cancer Alliances Faster Diagnosis Standard: 28 days to diagnosis - being piloted currently Cancer Dashboard: single, integrated Cancer Dashboard

RCGP and Cancer Research UK Workshop Alliances and Vanguards:

RCGP and Cancer Research UK Workshop https://www.cancerdata.nhs.uk/dashboard#?tab=Overview&ccg=03T

RCGP and Cancer Research UK Workshop National Cancer Diagnosis Audit https://www.cancerdata.nhs.uk/dashboard#?tab=Overview&ccg=03T

RCGP and Cancer Research UK Workshop National Cancer Diagnosis Audit Primary and secondary care data for patients diagnosed with cancer in 2014 England: 439 GP practices took part 17,043 (5.74%) patient pathways to cancer diagnosis Participating practices provided with a tailored report on their data to help highlight good practice and identify areas for quality improvement National results of the England audit have been published in the BJGP https://doi.org/10.3399/bjgp17X694169 https://doi.org/10.3399/bjgp17X694169

RCGP and Cancer Research UK Workshop National Cancer Diagnosis Audit https://doi.org/10.3399/bjgp17X694169

RCGP and Cancer Research UK Workshop National Cancer Diagnosis Audit https://doi.org/10.3399/bjgp17X694169

RCGP and Cancer Research UK Workshop National Cancer Diagnosis Audit Consultations prior to referral (where recorded) Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first

RCGP and Cancer Research UK Workshop National Cancer Diagnosis Audit The audit will be repeated (data collection to start in 2019) https://doi.org/10.3399/bjgp17X694169

RCGP and Cancer Research UK Workshop “Non-communicable diseases are a slow-motion disaster; these are the diseases that break the bank”. Dr. Margaret Chan, Former Director-General of WHO

RCGP and Cancer Research UK Workshop Key to cancer

RCGP and Cancer Research UK Workshop Key to cancer Education

RCGP and Cancer Research UK Workshop Key to cancer Education – public Education – patients Education – profession

RCGP and Cancer Research UK Workshop Key to cancer Education – public Education – patients Education – profession Education – policy makers

RCGP and Cancer Research UK Workshop Key to cancer Education – public Education – patients Education – profession Education – policy makers Education – politicians

RCGP and Cancer Research UK Workshop Insanity:

RCGP and Cancer Research UK Workshop Insanity: doing the same thing over and over again and expecting different results

RCGP and Cancer Research UK Workshop Insanity: doing the same thing over and over again and expecting different results Albert Einstein 1879-1955

RCGP and Cancer Research UK Workshop Our common goal?

RCGP and Cancer Research UK Workshop Our common goal?

RCGP and Cancer Research UK Workshop Our common goal? We are doing amazingly,

RCGP and Cancer Research UK Workshop Our common goal? We are doing amazingly, but if resourced we can do even better, and match the best health care systems…

RCGP and Cancer Research UK Workshop Our common goal? We are doing amazingly, but if resourced we can do even better, and match the best health care systems… As a wider health community we could do so much more …if resourced properly: We need to spend money now… to save money (and misery) later

RCGP and Cancer Research UK Workshop Primary Care and Cancer Control Cancer: why all the interest? Why is early diagnosis important? Past – where were we? Present – where are we? Future – where next? Survivorship End of life care

RCGP and Cancer Research UK Workshop One person can make a difference, and everyone should try.

RCGP and Cancer Research UK Workshop One person can make a difference, and everyone should try. John F Kennedy 1917-1963

RCGP and Cancer Research UK Workshop Thank you

RCGP and Cancer Research UK Workshop Any questions?